Haoxi Health Technology Limited
HAO
$0.98
-$0.03-3.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -63.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -63.06% | |||
| Cost of Revenue | 0.00% | -64.21% | |||
| Gross Profit | 0.00% | -6.87% | |||
| SG&A Expenses | 0.00% | 327.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | -55.48% | |||
| Operating Income | 0.00% | -1,369.86% | |||
| Income Before Tax | 0.00% | 207,170.00% | |||
| Income Tax Expenses | 0.00% | -84.57% | |||
| Earnings from Continuing Operations | 0.00% | 1,866.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 1,866.64% | |||
| EBIT | 0.00% | -1,369.86% | |||
| EBITDA | 0.00% | -1,247.54% | |||
| EPS Basic | 0.00% | 1,223.24% | |||
| Normalized Basic EPS | 0.00% | 113,400.00% | |||
| EPS Diluted | 0.00% | 990.80% | |||
| Normalized Diluted EPS | 0.00% | 108,600.00% | |||
| Average Basic Shares Outstanding | 0.00% | 57.23% | |||
| Average Diluted Shares Outstanding | 0.00% | 64.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||